Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,909 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Active, Not Recruiting

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

NCT02101853

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +15 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
View all 186 locations
View Trial Details
Active, Not Recruiting

Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)

NCT03998254

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +10 more
Locations
  • Lingchuan Center for Disease Control and Prevention ( Site 0002) Guilin, Guangxi, China
  • Quanzhou Center for Disease Control and Prevention ( Site 0001) Guilin, Guangxi, China
  • Xiangyuan Center for Disease Control and Prevention ( Site 0003) Changzhi, Shanxi, China
  • Yanhu Center for Disease Control and Prevention of Yuncheng ( Site 0004) Yuncheng, Shanxi, China
View Trial Details
Active, Not Recruiting

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

NCT03036930

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia

NCT02879695

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
Locations
  • Yale University New Haven, Connecticut, United States
  • University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over

NCT06569823

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +5 more
Locations
  • Paratus Clinical Research Western Syndney Blacktown, New South Wales, Australia
  • Emeritus Research Botany, New South Wales, Australia
  • Canopy Clinical Northern Beaches Brookvale, New South Wales, Australia
  • Paratus Clinical Research Central Coast Kanwal, New South Wales, Australia
View all 16 locations
View Trial Details

Related conditions